封面
市场调查报告书
商品编码
1373848

全球避孕药具和避孕器市场(2023-2030):规模、份额、成长分析和类型预测(口服避孕药(避孕药)/子宫内避孕器)

Global Contraceptives Market Size, Share, Growth Analysis, By Type(oral contraceptives (birth control pills), intrauterine devices (IUDs)) - Industry Forecast 2023-2030

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

全球避孕药和避孕器市场规模将从 2021 年的 232 亿美元成长到 2022 年的 282.2 亿美元,预测期内年复合成长率为 7.4%,到 2030 年将成长到 499.6 亿美元。

全球避孕药和避孕器市场正在经历显着成长,并受到多种因素的推动。计划生育意识的提高、性行为感染(STI)盛行率的上升以及对有效避孕方法的需求不断增加是推动市场成长的主要因素。此外,避孕技术的进步,例如长效可逆避孕药具和避孕器(LARC)的开发以及多种避孕选择的出现,也推动了市场的扩张。此外,旨在促进计划生育和生殖健康的政府配合措施和计划也为市场创造了有利的环境。

然而,社会耻辱、文化障碍以及某些地区获得避孕器的机会有限等挑战正在抑制因素市场成长。

本报告调查了全球避孕药和避孕器市场,并提供了市场概况、影响市场的各种因素分析、技术和创新趋势、法律制度、市场规模趋势和预测以及各个细分市场和地区。编制了单独的细分、竞争形势、主要企业简介等。

目录

  • 执行摘要
  • 调查方法
  • 母市场分析
    • 市场概况
    • 市场规模
    • 市场动态
      • 促进因素
      • 机会
      • 抑制因素
      • 任务
  • 关键市场洞察
    • 技术分析
    • 价格分析
    • 供应链分析
    • 价值链分析
    • 市场生态系统
    • 智慧财产权分析
    • 贸易分析
    • 启动分析
    • 原料分析
    • 创新矩阵
    • 研发线产品分析
    • 总体经济指标
    • 重点投资分析
    • 关键成功因素
    • 竞争程度
    • 市场动态及展望
      • 市场动态
        • 促进因素
        • 机会
        • 抑制因素
        • 任务
    • 法规状况
    • 波特的分析
    • Skyquest 对未来颠覆的独家见解
  • 全球避孕药和避孕器市场:按类型
    • 市场概况
    • 口服避孕药(避孕药)
    • 子宫内避孕器 (IUD)
    • 保险套
    • 避孕贴片
    • 注射避孕药
    • 更多的
  • 全球避孕药和避孕器市场:按地区
    • 市场概况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东/非洲
  • 竞争形势
    • 前5名企业对比
    • 主要企业市场地位
    • 主要企业的招募策略
    • 关键成功策略
    • 近期市集活动
    • 主要企业市场占有率
  • 主要企业简介
    • Pfizer Inc.
    • Bayer AG
    • Merck & Co., Inc.
    • Johnson & Johnson Services, Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Mylan NV
    • Allergan plc
    • Reckitt Benckiser Group plc
    • Church & Dwight Co., Inc.
    • Mankind Pharma Ltd.
    • CooperSurgical, Inc.
    • Medisafe Distribution Inc
    • HLL Lifecare Limited
    • Mayer Laboratories, Inc.
    • Lupin Limited
    • Okamoto Industries, Inc
    • Actavis, Inc.
    • Ansell Limited
    • Cipla Limited
    • anssen Pharmaceuticals, Inc.
简介目录
Product Code: SQMIG35I2174

Global Contraceptives Market size was valued at USD 23.20 billion in 2021 and is poised to grow from USD 28.22 billion in 2022 to USD 49.96 billion by 2030, growing at a CAGR of 7.4% in the forecast period (2023-2030).

The global contraceptives market is witnessing significant growth and is driven by several factors. Increasing awareness about family planning, rising prevalence of sexually transmitted infections (STIs), and the growing demand for effective contraceptive methods are key factors contributing to market growth. Additionally, advancements in contraceptive technologies, such as the development of long-acting reversible contraceptives (LARCs) and the availability of a wide range of contraceptive options, are further fueling market expansion. Moreover, government initiatives and programs aimed at promoting family planning and reproductive health are creating a favorable environment for the market. However, challenges such as social stigma, cultural barriers, and limited access to contraceptives in certain regions pose restraints to market growth. Nonetheless, the increasing emphasis on women's health and the rising acceptance of contraception as a means of empowerment are expected to drive the growth of the global contraceptives market in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Emergency Lighting Systems Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Contraceptives Market Segmental Analysis

The global contraceptives market is segmented by type, application, and region. Based on type, the market can be segmented into oral contraceptives (birth control pills), intrauterine devices (IUDs), condoms, contraceptive patches, injectable contraceptives, and more. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Contraceptives Market Dynamics

Drivers of the Global Contraceptives Market

Increasing Awareness And Acceptance Of Family Planning And Reproductive Health

One key driver of the global contraceptives market is the increasing awareness and acceptance of family planning and reproductive health. As societies become more educated and aware about the importance of contraception in controlling population growth and promoting women's health, the demand for contraceptives has witnessed significant growth. Additionally, government initiatives and programs aimed at promoting family planning, along with the efforts of various organizations in spreading awareness about contraceptive methods, have also contributed to the market's growth.

Restraints in the Global Contraceptives Market

Cultural And Religious Barriers That Limit The Use And Acceptance Of Contraceptives

A major restraint in the global contraceptives market is the cultural and religious barriers that limit the use and acceptance of contraceptives in certain regions. In some societies, there are cultural or religious beliefs that discourage or restrict the use of contraceptives, leading to lower adoption rates. Moreover, inadequate access to contraceptives, particularly in rural and remote areas, can also act as a restraint. Limited availability, affordability, and lack of proper distribution channels can hinder the widespread use of contraceptives, especially in developing countries. Overcoming these cultural and logistical challenges is crucial for the market's further growth and ensuring universal access to effective contraception methods.

Market Trends of the Global Contraceptives Key

One key market trend in the global contraceptives market is the increasing demand for long-acting reversible contraceptives (LARCs). LARCs include methods such as intrauterine devices (IUDs) and contraceptive implants. These methods offer a high level of effectiveness and convenience, as they require less frequent administration compared to other contraceptive options. LARCs are preferred by women seeking reliable and hassle-free contraception, contributing to their growing popularity. Additionally, advancements in technology have led to the development of more innovative and user-friendly LARCs, further driving their adoption. The trend towards LARCs reflects a shift towards more effective and sustainable contraceptive methods in the global market.

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
    • Regulatory Landscape
    • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Contraceptives Market by Type
    • Market Overview
    • oral contraceptives (birth control pills)
    • intrauterine devices (IUDs)
    • condoms
    • contraceptive patches
    • injectable contraceptives
    • and more
  • Global Contraceptives Market Size by Region
    • Market Overview
    • North America
  • USA
  • Canada
    • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
    • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
    • Latin America
  • Brazil
  • Rest of Latin America
    • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
  • By Development
  • By Company
  • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • Pfizer Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Merck & Co., Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Johnson & Johnson Services, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Mylan N.V. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Allergan plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Reckitt Benckiser Group plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Church & Dwight Co., Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Mankind Pharma Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • CooperSurgical, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Medisafe Distribution Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • HLL Lifecare Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Mayer Laboratories, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Lupin Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Okamoto Industries, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Actavis, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Ansell Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Cipla Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • anssen Pharmaceuticals, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments